The novel treatment consists of a single shot which is made of special proteins called antibodies that bind to the site at ...

The other vaccine, mResvia, is an mRNA-based vaccine that sends signals to your cells to produce the same protein F that causes the immune reaction that fights against RSV. These vaccines are ...

Eleven drugs are poised to reach blockbuster status, dramatically improving patient outcomes on a global scale.

The U.S. is seeing a "quad-demic" as cases of COVID-19, flu, RSV and norovirus spread at the same time. Experts said this is what you need to know. The so-called "quad-demic" includes flu ...

UK firm Swarm Oncology launches with a T-cell therapy platform to treat solid tumours, with a Resolution Therapeutics co-founder in the pilot seat. The FDA has started a review of MSD's RSV ...

Traditionally, the microbiologic diagnosis of RSV has been based on moderate to complex techniques performed in a laboratory (cell culture, nucleic acid amplification and immunofluorescence assays ...

They’re also seeing an increase in strep throat and a lot of RSV in all age groups ... as a result of disrupting the function of the cells of the stomach and intestines. It often starts with ...

S-337395 is an investigational oral antiviral candidate for RSV infection that inhibits the activity of the L protein, which is essential for virus replication. 1,2 Furthermore, this drug has received ...

FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.